MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2017 International Congress

    Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson’s disease and multiple system atrophy

    K.J. Kim, J.-M. Kim (Seongnam-Si, Republic of Korea)

    Objective: To compare the features of urinary dysfunction in Progressive supranuclear palsy (PSP) with those of idiopathic Parkinson’s disease (IPD) and multiple system atrophy (MSA). Background:…
  • 2017 International Congress

    Blink reflex recovery cycle to differentiate Progressive Supranuclear Palsy from Corticobasal Degeneration

    G. Sciacca, A. Nicoletti, G. Mostile, A. Luca, L. Raciti, V. Dibilio, F. Le Pira, M. Zappia (Catania, Italy)

    Objective: To evaluate R2 Blink Reflex Recovery Cycle (BRRC) in patients with Progressive Supranuclear Palsy (PSP) and CorticoBasal Degeneration (CBD) and to determine its diagnostic…
  • 2017 International Congress

    Brain metabolic patterns in progressive supranuclear palsy phenotypes

    M.M. Carmona-Abellan, A. Fontes, E. Prieto, J. Arbizu, R. Luquin, M. Riverol (Pamplona, Spain)

    Objective: To describe changes in cerebral glucose metabolism in patients with different described clinical phenotypes of PSP and to correlate them with the clinical manifestations of the disease. Background:…
  • 2017 International Congress

    Neuropsychiatric and Cognitive Predictors of Early Diagnosis of Progressive Supranuclear Palsy

    C. Pellicano, F. Assogna, N. Cellupica, M. Pierantozzi, A. Stefani, R. Cerroni, B. Mercuri, C. Caltagirone, F. Pontieri, G. Spalletta (Rome, Italy)

    Objective: To define differences of neuropsychiatric and neuropsychological profile among Progressive Supranuclear Palsy (PSP) -Richardson syndrome (PSP-RS), PSP-parkinsonism (PSP-P), and Parkinson’s disease (PD), in order…
  • 2017 International Congress

    Gait and Cognition in Progressive Supranuclear Palsy: A Significant Association

    K. Chatterjee, B. Mondal, S. Choudhury, H. Kumar (Kolkata, India)

    Objective: In this study we explored the association between gait parameters and cognitive function of PSP. Background: Gait and cognition are interrelated in patients with…
  • 2017 International Congress

    Anatomical predictors of survival in PSP: thalamic collapse towards the end of life

    W. Bevan-Jones, S. Jones, B. Ghosh, T. Rittman, I. Coyle-Gilchrist, J. Rowe (Cambridge, United Kingdom)

    Objective: To correlate anatomical changes with time to death in PSP. Background: Many advances have been made in progressive supranuclear palsy (PSP) since it was first described…
  • 2017 International Congress

    Gait characteristics in Atypical Parkinsonism

    S. Radovanovic, M. Jecmenica-Lukic, I. Petrovic, N. Dragasevic-Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: We investigated gait characteristics of progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), with the aim to elucidate relatively specific disease differences in…
  • 2017 International Congress

    Clinicopathological analysis of corticobasal syndrome: a retrospective study

    R. Lamb, J. Rohrer, R. Weil, H. Ling, A. Lees, H. Morris (London, United Kingdom)

    Objective: Predicting underlying pathology in CBS. Background: Corticobasal syndrome (CBS) is pathologically heterogeneous.  CBS is one of the clinical phenotypes of corticobasal degeneration (CBD) but may…
  • 2016 International Congress

    Non-motor symptoms in progressive supranuclear palsy

    R. Ou, W. Song, Q. Wei, K. Chen, B. Cao, Y. Hou, B. Zhao, H. Shang (Chengdu, People's Republic of China)

    Objective: To explore the clinical correlates of Non-motor symptoms (NMS) in progressive supranuclear palsy (PSP) and their differences from healthy aging and Parkinson's disease (PD).…
  • 2016 International Congress

    A cross-sectional study of sensor-based gait analysis in atypical Parkinsonian disorders

    C. Raccagni, H. Gassner, S. Eschlböck, S. Bösch, F. Krismer, M. Nocker, K. Seppi, W. Poewe, J. Klucken, G. Wenning (Innsbruck, Austria)

    Objective: Primary objective was to identify quantitative markers of gait impairment in patients with idiopathic Parkinson's disease (IPD), atypical Parkinsonian disorders (APD) and healthy controls…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley